Accelerate Diagnostics (AXDX) Stock Analysis
NASDAQHealthcareMedical - Devices
What Accelerate Diagnostics does
Accelerate Diagnostics, Inc. is an in vitro diagnostics company specializing in solutions for the rapid diagnosis of critical infections, with operations spanning the United States, Europe, and the Middle East. The company's primary offering is the Accelerate Pheno system, an advanced in vitro diagnostic platform. Paired with its dedicated test kit, the Accelerate PhenoTest, this system facilitates quick identification and antimicrobial susceptibility testing (AST) for pathogens responsible for severe or healthcare-associated infections, encompassing both Gram-positive and Gram-negative organisms. The PhenoTest is specifically designed to yield crucial ID and AST results for patients suspected of bacteremia or fungemia – life-threatening conditions marked by high morbidity and mortality risks. Established in 1982, the company initially operated as Accelr8 Technology Corporation before adopting its current name, Accelerate Diagnostics, Inc., in December 2012. Its corporate headquarters are located in Tucson, Arizona.
Key metrics
ETFs linked to AXDX
Broad-market and Healthcare sector ETFs an investor holding Accelerate Diagnostics is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how AXDX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze AXDX in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Accelerate Diagnostics?
- Accelerate Diagnostics trades under the ticker AXDX on NASDAQ.
- Which exchange is AXDX listed on?
- AXDX is listed on NASDAQ.
- What sector does Accelerate Diagnostics operate in?
- Accelerate Diagnostics is classified in the Healthcare sector (Medical - Devices industry).
- How can PortView help analyze AXDX in a portfolio?
- PortView shows AXDX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.